SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-008022
Filing Date
2024-02-14
Accepted
2024-02-14 16:42:00
Documents
9
Period of Report
2024-02-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20014884x6_def14a.htm DEF 14A 2932565
2 logo_cartesian.jpg GRAPHIC 42894
3 ny20014884x6_graphic-1.jpg GRAPHIC 245271
4 ny20014884x6_graphic-2.jpg GRAPHIC 121823
5 ny20014884x6_graphic-3.jpg GRAPHIC 142066
6 ny20014884x6_graphic-4.jpg GRAPHIC 271867
7 ny20014884x6_graphic-5.jpg GRAPHIC 208872
8 ny20014884x6_pc-1.jpg GRAPHIC 623570
9 ny20014884x6_pc-2.jpg GRAPHIC 677988
  Complete submission text file 0001140361-24-008022.txt   6146856
Mailing Address 65 GROVE STREET WATERTOWN MA 02472
Business Address 65 GROVE STREET WATERTOWN MA 02472 617-923-1400
Cartesian Therapeutics, Inc. (Filer) CIK: 0001453687 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37798 | Film No.: 24639539
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)